Related Experiment Videos
Huntington's disease: Current and future therapeutic prospects
Karl Kieburtz1, Ralf Reilmann2, C Warren Olanow3
1University of Rochester, USA and Clintrex LLC.
Summary
New Huntington's disease (HD) therapies show promise, targeting the underlying causes beyond just chorea. Research is advancing clinical trials and identifying new therapeutic targets for this progressive neurodegenerative disorder.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder.
- Current treatments for HD are inadequate and do not halt disease progression.
- Approved therapies primarily manage chorea, neglecting other significant motor, behavioral, and cognitive symptoms.
Purpose of the Study:
- To review emerging therapies for Huntington's disease.
- To discuss advancements in clinical trials and outcome measures for HD.
- To identify and explore novel therapeutic targets for HD.
Main Methods:
- Literature review of preclinical and clinical studies on HD therapies.
- Analysis of current clinical trial designs and endpoints in HD research.
- Identification of potential molecular and cellular targets for therapeutic intervention.
Main Results:
- A wide range of novel therapeutic strategies are under investigation for HD.
- Progress is being made in refining clinical trial methodologies and endpoints.
- Several new targets show potential for addressing the multifaceted nature of HD.
Conclusions:
- Despite current limitations, promising new therapies for Huntington's disease are emerging.
- Advances in clinical research are paving the way for more effective treatments.
- Targeting novel pathways offers hope for halting or reversing HD progression.